CoChat

Fatigue, Inflammation, and ω-3 and ω-6 Fatty Acid Intake Among Breast Cancer Survivors

Open access
Alfano, Catherine M., Imayama, Ikuyo, Neuhouser, Marian L., Kiecolt-Glaser, Janice K., Smith, Ashley Wilder, Meeske, Kathleen, McTiernan, Anne, Bernstein, Leslie, Baumgartner, Kathy B., Ulrich, Cornelia M., Ballard-Barbash, Rachel · 2012 · Journal of Clinical Oncology
Cited by 152

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Purpose: Evidence suggests that inflammation may drive fatigue in cancer survivors. Research in healthy populations has shown reduced inflammation with higher dietary intake of ω-3 polyunsaturated fatty acids (PUFAs), which could potentially reduce fatigue. This study investigated fatigue, inflammation, and intake of ω-3 and ω-6 PUFAs among breast cancer survivors. Methods: Six hundred thirty-three survivors (mean age, 56 years; stage I to IIIA) participating in the Health, Eating, Activity, and Lifestyle Study completed a food frequency/dietary supplement questionnaire and provided a blood sample assayed for C-reactive protein (CRP) and serum amyloid A (30 months after diagnosis) and completed the Piper Fatigue Scale and Short Form-36 (SF-36) vitality scale (39 months after diagnosis). Analysis of covariance and logistic regression models tested relationships between inflammation and fatigue, inflammation and ω-3 and ω-6 PUFA intake, and PUFA intake and fatigue, controlling for three incremental levels of confounders. Fatigue was analyzed continuously (Piper scales) and dichotomously (SF-36 vitality ≤ 50). Results: Behavioral (P = .003) and sensory (P = .001) fatigue scale scores were higher by increasing CRP tertile; relationships were attenuated after adjustment for medication use and comorbidity. Survivors with high CRP had 1.8 times greater odds of fatigue after full adjustment (P < .05). Higher intake of ω-6 relative to ω-3 PUFAs was associated with greater CRP (P = .01 after full adjustment) and greater odds of fatigue (odds ratio, 2.6 for the highest v lowest intake; P < .05). Conclusion: Results link higher intake of ω-3 PUFAs, decreased inflammation, and decreased physical aspects of fatigue. Future studies should test whether ω-3 supplementation may reduce fatigue among significantly fatigued breast cancer survivors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2011.36.4109

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 51

  1. 10.1097/00000446-200603003-00025 · DOI
  2. 10.1093/jncimonographs/lgh027 · DOI · Paper page
  3. 10.1002/cncr.21671 · DOI · Paper page
  4. 10.1188/04.ONF.591-598 · DOI · Paper page
  5. Stepanski EJ, 2009, J Clin Sleep Med, 5, 132, 10.5664/jcsm.27441 · DOI
  6. 10.1634/theoncologist.12-S1-35 · DOI · Paper page
  7. 10.1016/j.ejca.2008.09.010 · DOI · Paper page
  8. 10.1016/j.soncn.2007.01.004 · DOI
  9. 10.1634/theoncologist.5-5-353 · DOI · Paper page
  10. 10.1016/j.bbi.2006.11.004 · DOI · Paper page
  11. 10.1200/JCO.2007.10.7805 · DOI · Paper page
  12. 10.1159/000079408 · DOI · Paper page
  13. 10.1158/1078-0432.CCR-05-2398 · DOI · Paper page
  14. 10.1002/cncr.11382 · DOI · Paper page
  15. 10.1016/j.bbi.2010.09.010 · DOI · Paper page
  16. 10.1038/ejcn.2009.20 · DOI
  17. 10.3945/ajcn.2009.28820 · DOI
  18. 10.1016/j.nutres.2008.03.008 · DOI
  19. 10.1016/j.amjcard.2009.01.016 · DOI · Paper page
  20. 10.1016/S0002-9149(01)02049-5 · DOI
  21. 10.1016/j.atherosclerosis.2008.12.013 · DOI · Paper page
  22. 10.1056/NEJM198902023200501 · DOI · Paper page
  23. 10.1093/ajcn/63.1.116 · DOI · Paper page
  24. 10.1093/jn/121.4.547 · DOI · Paper page
  25. 10.1007/s11695-007-9062-x · DOI
  26. 10.1093/jn/129.6.1120 · DOI
  27. 10.1016/j.nut.2005.03.001 · DOI
  28. 10.1080/01635580701365068 · DOI · Paper page
  29. 10.3748/wjg.14.2434 · DOI · Paper page
  30. 10.1200/JCO.2003.07.057 · DOI · Paper page
  31. 10.1016/S1047-2797(01)00274-5 · DOI
  32. 10.1002/ijc.20072 · DOI
  33. Piper BF, 1998, Oncol Nurs Forum, 25, 677
  34. Ware JE, 1992, Conceptual framework and item selection. Med Care, 30, 473
  35. 10.1249/MSS.0b013e31819c7feb · DOI · Paper page
  36. 10.1016/S1047-2797(98)00055-6 · DOI · Paper page
  37. 10.1007/s10549-007-9834-y · DOI
  38. 10.1002/dmr.5610080404 · DOI
  39. Pereira MA, 1997, Med Sci Sports Exerc, 29, S1, 10.1097/00005768-199705001-01074 · DOI · Paper page
  40. 10.1073/pnas.0610362104 · DOI · Paper page
  41. 10.1111/j.1527-3466.2006.00033.x · DOI · Paper page
  42. 10.1016/j.bbi.2009.05.053 · DOI
  43. Wener MH, 2000, J Rheumatol, 27, 2351
  44. 10.1016/j.clinthera.2007.02.006 · DOI
  45. 10.1200/JCO.2008.18.9068 · DOI · Paper page
  46. 10.1017/S0954422408998620 · DOI · Paper page
  47. 10.1161/01.HYP.0000145292.38579.f4 · DOI
  48. Maes M, 2005, Neuro Endocrinol Lett, 26, 745
  49. 10.1592/phco.27.5.633 · DOI
  50. 10.1007/s10549-008-9985-5 · DOI
  51. 10.1016/S0022-1759(98)00057-X · DOI

Cited by

See all 152

Metadata

Authors
Alfano, C. M., Imayama, I., Neuhouser, M. L., Kiecolt-Glaser, J. K., Smith, A. W., Meeske, K., McTiernan, A., Bernstein, L., Baumgartner, K. B., Ulrich, C. M., & Ballard-Barbash, R.
Venue
Journal of Clinical Oncology
Published
2012-04-20
Volume
30
Issue
12
Pages
1280-1287
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2123963828
Cited by
152
References
8
FWCI
8.42
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fatigue, Inflammation, and ω-3 and ω-6 Fatty Acid Intake Among Breast Cancer Survivors. https://app.cochat.ai/papers/10.1200/jco.2011.36.4109
The paper
Alfano, C. M., Imayama, I., Neuhouser, M. L., Kiecolt-Glaser, J. K., Smith, A. W., Meeske, K., McTiernan, A., Bernstein, L., Baumgartner, K. B., Ulrich, C. M., & Ballard-Barbash, R. (2012). Fatigue, Inflammation, and ω-3 and ω-6 Fatty Acid Intake Among Breast Cancer Survivors. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2011.36.4109

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.